Dr. Robert Winn closes #Ginder26 out with his signature #OneTeamOneFight style.

Patients Elner Capati and Christine Patafio share their inspiring cancer journeys with the audience at #Ginder26 and discuss the challenges and hope involved with clinical trials

NC State University's Cathrine Hoyo, PhD is explains how environmental factors can leave "epigenetic scars" on our DNA. This research shows how our geography & early-life stressors drive liver cancer risk, and offer a possible path for early detection. #Ginder26

Shelley Berger, PhD and Peter Jones, PhD tackle excellent questions from the audience at #Ginder26.

UPenn - Perelman School of Medicine's Dr. Shelley Berger delves into the latest research with protein gene expression patterns that could predict patient survival in kidney cancer. #Ginder26

The @vai.org'sPeter Jones, PhD discusses the targeting of TET2 and intercepting myeloid cancers with Vitamin C at #Ginder26.

Krista Dalton, PhD starts us off by answering 'what is epigenetics in cancer'? #Ginder26

Collectible pins, a hearty breakfast, and stirring invocation from Facts and Faith Fridays Rev. Rachel - #Ginder26 is off to a great start! Join us on LinkedIn, Bluesky, and Twitter for updates throughout the day. #OneTeamOneFight